- 2024,12,26
The first step in stock trading is to open a stock account
A report from our correspondent (reporter wuyixuan) on the evening of December 23, Zhejiang sincerity Pharmaceutical Co., Ltd. (hereinafter referred to as "sincerity pharmaceutical") issued a progress announcement on the repurchase of shares by centralized bidding to reach 2%. As of December 23, the company has repurchased about 6.9602 million shares through centralized bidding transactions, accounting for 2.13% of the company's total share capital. The highest transaction price is 8.36 yuan/share, the lowest transaction price is 7.36 yuan/share, and the total amount of funds paid is about 55.9884 million yuan (excluding transaction costs). The sources of funds for repurchasing shares are the company's own funds and special loan funds for share repurchases.
Among them, the source of the special loan for stock repurchase is sincere pharmaceutical, which actively responded to the notice on matters related to the establishment of stock repurchase and shareholding increase refinancing issued by the people's Bank of China, the State Administration of financial supervision and the China Securities Regulatory Commission, cooperated with financial institutions and obtained the support of the branches of China Construction Bank Corporation. China Construction Bank Corporation authorized its branches to issue the China Construction Bank loan commitment letter, agreeing to provide the company with a special loan for stock repurchase of no more than 50million yuan, with a loan term of one year.
Sincerity pharmaceutical said that this repurchase is based on the company's confidence in future development and high recognition of the company's value. It aims to establish and improve the company's long-term incentive mechanism, fully mobilize the enthusiasm of the company's employees, improve team cohesion and competitiveness, and effectively combine the interests of shareholders, the company and employees.